Nxera Pharma Co., Ltd. (TYO:4565)
Japan · Delayed Price · Currency is JPY 1,013.00
-1.00 (-0.10%)
Apr 20, 2026, 10:20 AM JST
Nxera Pharma Market Cap
Nxera Pharma has a market cap or net worth of 91.67 billion as of April 17, 2026. Its market cap has increased by 10.00% in one year.
Market Cap
91.67B
Enterprise Value
128.69B
Revenue
29.62B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,013.00
Market Cap Chart
Since July 29, 2004, Nxera Pharma's market cap has increased from 38.40B to 91.67B, an increase of 138.75%. That is a compound annual growth rate of 4.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 91.67B | 22.49% |
| Dec 30, 2025 | 74.84B | -20.57% |
| Dec 30, 2024 | 94.22B | -25.87% |
| Dec 29, 2023 | 127.10B | -27.43% |
| Dec 30, 2022 | 175.15B | 12.85% |
| Dec 30, 2021 | 155.21B | 7.00% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GNI Group | 187.66B |
| SanBio Company | 163.17B |
| PeptiDream | 152.80B |
| Takara Bio | 137.51B |
| Oncolys BioPharma | 83.72B |
| Cuorips | 58.22B |
| Healios K.K. | 49.95B |
| Japan Tissue Engineering | 24.65B |